These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7038206)

  • 1. [Development of new antileukemic agents].
    Yamada K; Ohno R
    Nihon Rinsho; 1981 Aug; 39(8):2815-20. PubMed ID: 7038206
    [No Abstract]   [Full Text] [Related]  

  • 2. [Symposium on treatment of cancer. 1. Chemotherapy of acute leukemia in adults].
    Yamada K
    Nihon Naika Gakkai Zasshi; 1984 Nov; 73(11):1585-9. PubMed ID: 6394671
    [No Abstract]   [Full Text] [Related]  

  • 3. Overview of progress in hematology in 1981 with special reference to leukocyte.
    Kimura K
    Nihon Ketsueki Gakkai Zasshi; 1982 Feb; 45(1):1-10. PubMed ID: 7051724
    [No Abstract]   [Full Text] [Related]  

  • 4. Aclarubicin in the treatment of acute nonlymphocytic leukemia refractory to treatment with daunorubicin and cytarabine: a phase II trial.
    Pedersen-Bjergaard J; Brincker H; Ellegaard J; Drivsholm A; Freund L; Jensen KB; Jensen MK; Nissen NI
    Cancer Treat Rep; 1984 Oct; 68(10):1233-8. PubMed ID: 6597002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical studies of aclacinomycin A (ACM).
    Majima H; Ohta K
    Biomed Pharmacother; 1987; 41(5):233-7. PubMed ID: 3311189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [New agents in the treatment of leukemia and lymphoma].
    Yamada K
    Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 2):1031-40. PubMed ID: 6347079
    [No Abstract]   [Full Text] [Related]  

  • 7. Action mechanism of antileukemic agents with special reference to nucleic acid metabolism of leukemic cells.
    Nakamura T
    Nihon Ketsueki Gakkai Zasshi; 1982 Dec; 45(7):1203-18. PubMed ID: 6762793
    [No Abstract]   [Full Text] [Related]  

  • 8. Phase II trial of aclarubicin in epidermoid carcinoma of the head and neck.
    Carugati AA; Olivari AJ; Campos DM; Pradier R; Woolley PV
    Cancer Treat Rep; 1986 Jun; 70(6):799-800. PubMed ID: 3524828
    [No Abstract]   [Full Text] [Related]  

  • 9. Anthracyclines in the treatment of acute nonlymphocytic leukemias.
    Boiron M; Jacquillat C; Marty M; Weil M; Gisselbrecht C
    Cancer Treat Rep; 1981; 65 Suppl 4():73-6. PubMed ID: 6955013
    [No Abstract]   [Full Text] [Related]  

  • 10. Chemotherapy of acute leukemia in adults.
    Yamada K
    Jpn J Med; 1985 Feb; 24(1):73-5. PubMed ID: 3858569
    [No Abstract]   [Full Text] [Related]  

  • 11. [Therapeutic trials of aclarubicin in previously treated acute leukemias and hematosarcomas].
    Machover D; Goldschmidt E; Benavides M; Gastiaburu J; Vandenbulcke JM; Delgado M; Misset JL; Mathe G
    Pathol Biol (Paris); 1987 Jan; 35(1):79-86. PubMed ID: 3550616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II trial of aclacinomycin in acute leukemia and lymphosarcoma.
    Mathé G; Gil MA; Delgado M; Bayssas M; Gouveia J; Ribaud P; Machover D; Misset JL; de Vassal F; Schwarzenberg L; Jasmin C; Hayat M
    Recent Results Cancer Res; 1980; 74():217-22. PubMed ID: 6893752
    [No Abstract]   [Full Text] [Related]  

  • 13. Phase II evaluation of aclarubicin in refractory multiple myeloma: a Southeastern Cancer Study Group Trial.
    Gockerman JP; Silberman H; Bartolucci AA
    Cancer Treat Rep; 1987; 71(7-8):773-4. PubMed ID: 3300970
    [No Abstract]   [Full Text] [Related]  

  • 14. Phase II evaluation of aclarubicin in lung cancer: a Southeastern Cancer Study Group Trial.
    Kramer BS; Birch R; Gockerman JP; Greco A; Prestridge K
    Cancer Treat Rep; 1986 Jun; 70(6):803-4. PubMed ID: 3015404
    [No Abstract]   [Full Text] [Related]  

  • 15. A phase II study of aclacinomycin A in acute leukemia in adults.
    Yamada K; Nakamura T; Tsuruo T; Kitahara T; Maekawa T; Uzaka Y; Kurita S; Masaoka T; Takaku F; Hirota Y; Amaki I; Osamura S; Ito M; Nakano N; Oguro M; Inagaki J; Onozawa K
    Cancer Treat Rev; 1980 Dec; 7(4):177-82. PubMed ID: 6938305
    [No Abstract]   [Full Text] [Related]  

  • 16. Randomized trial of high-dose cytarabine versus amsacrine in acute myelogenous leukemia in relapse: a Leukemia Intergroup Study.
    Vogler WR; Preisler HD; Winton EF; Gottlieb AJ; Goldberg J; Brennan J; Grunwald H; Rai K; Browman G; Miller KB
    Cancer Treat Rep; 1986 Apr; 70(4):455-9. PubMed ID: 3516395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of antileukemic drugs on superoxide (O2-) production by human neutrophils].
    Katoh M; Shirai T; Umeda M; Yamaguchi R; Kaneko H; Ishikawa I; Yamauchi M; Kojima N
    Rinsho Ketsueki; 1987 Nov; 28(11):1948-55. PubMed ID: 2833643
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of juvenile chronic myelocytic leukemia with multidrug chemotherapy including aclacinomycin and N4-behenoyl-1-beta-D-arabinofuranosylcytosine.
    Ishii E; Matsuzaki A; Kato Y; Miyazaki S; Ueda K
    Nihon Ketsueki Gakkai Zasshi; 1986 Sep; 49(6):1297-9. PubMed ID: 3468729
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical evaluation of a new anthracycline antibiotic, aclacinomycin-A, in patients with advanced malignant lymphoma.
    Warrell RP; Kempin SJ
    Am J Clin Oncol; 1983 Feb; 6(1):81-4. PubMed ID: 6573124
    [No Abstract]   [Full Text] [Related]  

  • 20. Oral complications in adult leukemic patients undergoing chemotherapy.
    Morry R; Lavelle CL
    Dent Hyg (Chic); 1984 Aug; 58(8):356-60. PubMed ID: 6590380
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.